• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性感染中生物膜的患病率对一个长期以来的范例提出了挑战。

Prevalence of biofilms in acute infections challenges a longstanding paradigm.

作者信息

Kolpen Mette, Jensen Peter Østrup, Faurholt-Jepsen Daniel, Bjarnsholt Thomas

机构信息

Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.

Costerton Biofilm Center, Institute of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Biofilm. 2022 Jun 9;4:100080. doi: 10.1016/j.bioflm.2022.100080. eCollection 2022 Dec.

DOI:10.1016/j.bioflm.2022.100080
PMID:35721391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9198313/
Abstract

The significance of bacterial biofilm formation in chronic bacterial lung infections has long been recognized [1]. Likewise, chronic biofilm formation on medical devices is well accepted as a nidus for recurrent bacteremia [2,3]. Even though the prevailing paradigm relies on the dominance of planktonic bacteria in acute endobronchial infections, our understanding of the bacterial organization during acute infection is, so far, limited - virtually absent. However, by comparing similar clinical samples, we have recently demonstrated massive bacterial biofilm formation during acute lung infections resembling the immense bacterial biofilm formation during chronic lung infections. These findings pose major challenges to the basic paradigm of chronic infections being dominated by biofilm forming bacteria while acute infections are dominated by planktonic bacteria. As opposed to the similar high amount of bacterial biofilm found in chronic and acute lung infections, we found that the fast bacterial growth in acute lung infections differed from the slow bacterial growth in chronic lung infections. By highlighting these new findings, we review modes of improved treatment of biofilm infections and the relevance of bacterial growth rates for other bacterial biofilm infections than human lung infections.

摘要

长期以来,人们一直认识到细菌生物膜形成在慢性细菌性肺部感染中的重要性[1]。同样,医疗器械上形成的慢性生物膜被公认为是复发性菌血症的病灶[2,3]。尽管目前流行的范式认为急性支气管内感染中浮游细菌占主导地位,但到目前为止,我们对急性感染期间细菌组织的了解有限——几乎是空白。然而,通过比较相似的临床样本,我们最近证明了急性肺部感染期间会形成大量细菌生物膜,这类似于慢性肺部感染期间巨大的细菌生物膜形成。这些发现对慢性感染由形成生物膜的细菌主导而急性感染由浮游细菌主导的基本范式提出了重大挑战。与在慢性和急性肺部感染中发现的大量相似细菌生物膜不同,我们发现急性肺部感染中细菌的快速生长与慢性肺部感染中细菌的缓慢生长有所不同。通过强调这些新发现,我们回顾了改善生物膜感染治疗的模式以及细菌生长速率与除人类肺部感染之外的其他细菌生物膜感染的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564f/9198313/bc04f3b39fc3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564f/9198313/bc04f3b39fc3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564f/9198313/bc04f3b39fc3/gr1.jpg

相似文献

1
Prevalence of biofilms in acute infections challenges a longstanding paradigm.急性感染中生物膜的患病率对一个长期以来的范例提出了挑战。
Biofilm. 2022 Jun 9;4:100080. doi: 10.1016/j.bioflm.2022.100080. eCollection 2022 Dec.
2
Bacterial biofilms predominate in both acute and chronic human lung infections.细菌生物膜在急性和慢性人类肺部感染中占主导地位。
Thorax. 2022 Oct;77(10):1015-1022. doi: 10.1136/thoraxjnl-2021-217576. Epub 2022 Jan 11.
3
The role of bacterial biofilms in chronic infections.细菌生物膜在慢性感染中的作用。
APMIS Suppl. 2013 May(136):1-51. doi: 10.1111/apm.12099.
4
Antibiotic Minimal Selective Concentrations and Fitness Costs during Biofilm and Planktonic Growth.抗生素最小选择浓度和生物膜与浮游生长期间的适应代价。
mBio. 2022 Jun 28;13(3):e0144722. doi: 10.1128/mbio.01447-22. Epub 2022 Jun 13.
5
BdlA, DipA and induced dispersion contribute to acute virulence and chronic persistence of Pseudomonas aeruginosa.BdlA、DipA和诱导性扩散有助于铜绿假单胞菌的急性毒力和慢性持续性。
PLoS Pathog. 2014 Jun 5;10(6):e1004168. doi: 10.1371/journal.ppat.1004168. eCollection 2014 Jun.
6
Biofilm and Planktonic Antibiotic Resistance in Patients With Acute Exacerbation of Chronic Rhinosinusitis.慢性鼻-鼻窦炎急性加重患者的生物膜和浮游抗生素耐药性。
Front Cell Infect Microbiol. 2022 Jan 17;11:813076. doi: 10.3389/fcimb.2021.813076. eCollection 2021.
7
Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation.凝固酶阴性葡萄球菌对极低出生体重儿的抗生素敏感性:生物膜形成不同阶段细菌的综合比较。
Ann Clin Microbiol Antimicrob. 2010 May 27;9:16. doi: 10.1186/1476-0711-9-16.
8
Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance.纳米颗粒和抗生素存在下的生物膜形成病原菌的进化:适应现象和交叉耐药性。
J Nanobiotechnology. 2021 Sep 27;19(1):291. doi: 10.1186/s12951-021-01027-8.
9
Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections.抗菌肽在治疗细菌生物膜感染中的潜在应用。
Curr Pharm Des. 2015;21(1):67-84. doi: 10.2174/1381612820666140905124312.
10
Biofilm vs. planktonic bacterial mode of growth: which do human macrophages prefer?生物膜与浮游细菌生长模式:人类巨噬细胞更喜欢哪种?
Biochem Biophys Res Commun. 2013 Nov 29;441(4):947-52. doi: 10.1016/j.bbrc.2013.11.012. Epub 2013 Nov 14.

引用本文的文献

1
Biosourced Functional Hydroxybenzoate--Lactide Polymers with Antimicrobial Activity.具有抗菌活性的生物源功能性羟基苯甲酸-丙交酯聚合物
J Am Chem Soc. 2025 Jun 4;147(22):19230-19238. doi: 10.1021/jacs.5c04624. Epub 2025 May 17.
2
biofilms: implications for survival, transmission, and disease management.生物膜:对生存、传播及疾病管理的影响
Appl Environ Microbiol. 2025 Feb 19;91(2):e0191424. doi: 10.1128/aem.01914-24. Epub 2025 Jan 10.
3
Gram Negative Biofilms: Structural and Functional Responses to Destruction by Antibiotic-Loaded Mixed Polymeric Micelles.

本文引用的文献

1
Contribution of Exopolysaccharides Pel and Psl to Wound Infections.荚膜多糖 Pel 和 Psl 对伤口感染的贡献。
Front Cell Infect Microbiol. 2022 Apr 7;12:835754. doi: 10.3389/fcimb.2022.835754. eCollection 2022.
2
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
3
Bacterial biofilms predominate in both acute and chronic human lung infections.
革兰氏阴性菌生物膜:对抗生素负载混合聚合物胶束破坏的结构和功能反应
Microorganisms. 2024 Dec 23;12(12):2670. doi: 10.3390/microorganisms12122670.
4
Association of biofilm and microbial metrics with healing rate in older adults with chronic venous leg ulcers.生物膜和微生物指标与老年慢性静脉性腿部溃疡愈合率的关系。
Wound Repair Regen. 2024 Nov-Dec;32(6):858-871. doi: 10.1111/wrr.13230. Epub 2024 Oct 19.
5
Optimization of an in vitro Pseudomonas aeruginosa Biofilm Model to Examine Antibiotic Pharmacodynamics at the Air-Liquid Interface.优化体外铜绿假单胞菌生物膜模型,以研究气-液界面处抗生素的药效动力学。
NPJ Biofilms Microbiomes. 2024 Mar 1;10(1):16. doi: 10.1038/s41522-024-00483-y.
6
Combination treatment to improve mucociliary transport of Pseudomonas aeruginosa biofilms.联合治疗改善铜绿假单胞菌生物膜的黏液纤毛传输。
PLoS One. 2024 Feb 23;19(2):e0294120. doi: 10.1371/journal.pone.0294120. eCollection 2024.
7
Biofilm antimicrobial susceptibility testing: where are we and where could we be going?生物膜抗菌药敏试验:我们现在在哪里,我们可以去哪里?
Clin Microbiol Rev. 2023 Dec 20;36(4):e0002423. doi: 10.1128/cmr.00024-23. Epub 2023 Oct 9.
8
The biofilm community resurfaces: new findings and post-pandemic progress.生物膜群落再现:新发现和后疫情时代的进展。
J Bacteriol. 2023 Oct 26;205(10):e0016623. doi: 10.1128/jb.00166-23. Epub 2023 Sep 27.
细菌生物膜在急性和慢性人类肺部感染中占主导地位。
Thorax. 2022 Oct;77(10):1015-1022. doi: 10.1136/thoraxjnl-2021-217576. Epub 2022 Jan 11.
4
Organic Acids and Their Salts Potentiate the Activity of Selected Antibiotics against Pseudomonas aeruginosa Biofilms Grown in a Synthetic Cystic Fibrosis Sputum Medium.有机酸及其盐增强了选定抗生素对在合成囊性纤维化痰液培养基中生长的铜绿假单胞菌生物膜的活性。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0187521. doi: 10.1128/AAC.01875-21. Epub 2021 Nov 22.
5
The importance of understanding the infectious microenvironment.了解感染性微环境的重要性。
Lancet Infect Dis. 2022 Mar;22(3):e88-e92. doi: 10.1016/S1473-3099(21)00122-5. Epub 2021 Sep 7.
6
The future of biofilm research - Report on the '2019 Biofilm Bash'.生物膜研究的未来——关于“2019年生物膜研讨会”的报告
Biofilm. 2019 Dec 24;2:100012. doi: 10.1016/j.bioflm.2019.100012. eCollection 2020 Dec.
7
Improving antibiotic treatment of bacterial biofilm by hyperbaric oxygen therapy: Not just hot air.通过高压氧疗法改善对细菌生物膜的抗生素治疗:并非只是空谈。
Biofilm. 2019 Nov 4;1:100008. doi: 10.1016/j.bioflm.2019.100008. eCollection 2019 Dec.
8
Integrated Univariate, Multivariate, and Correlation-Based Network Analyses Reveal Metabolite-Specific Effects on Bacterial Growth and Biofilm Formation in Necrotizing Soft Tissue Infections.整合单变量、多变量和基于相关的网络分析揭示了代谢物对坏死性软组织感染中细菌生长和生物膜形成的特定影响。
J Proteome Res. 2020 Feb 7;19(2):688-698. doi: 10.1021/acs.jproteome.9b00565. Epub 2020 Jan 14.
9
Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms.微生物生物膜中的抗菌耐受性和代谢适应
Trends Microbiol. 2019 Oct;27(10):850-863. doi: 10.1016/j.tim.2019.05.003. Epub 2019 Jun 6.
10
Antibiotic therapy as personalized medicine - general considerations and complicating factors.作为个性化医疗的抗生素治疗——一般考量与复杂因素
APMIS. 2019 May;127(5):361-371. doi: 10.1111/apm.12951.